Friday, March 31, 2023 10:01:45 AM
Yesterday's PR did not help their cause and potentially opened up for accusations of having omitted information relating to the disappointing n of the PDD OLE trial. Not least because of their earlier claims of high rollover percentage of ELIGIBLE patients into the OLE extension.
I think investors can now see how meaningless a high percentage of eligible patients can be with a the absolute n, not unlike Odds Ratios with no n and claims of having met all endpoints.
Recent AVXL News
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
